Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SpringerOpen
2024-11-01
|
| 叢編: | Future Journal of Pharmaceutical Sciences |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1186/s43094-024-00746-7 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|